Given prior reports of synergy between CHEK1 and WEE1 inhibitors in lymphoma [48], leukemia [11], and solid tumor [12, 49] cell lines, we suspected that simultaneous inhibition of CHEK1 and WEE1 might further magnify the synthetic lethal effect with RAD17 knockdown. Here, RAD17 is linked to leukemia.